Matches in Wikidata for { <http://www.wikidata.org/entity/Q104509931> ?p ?o ?g. }
- Q104509931 description "2020 nî lūn-bûn" @default.
- Q104509931 description "2020 թվականի նոյեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q104509931 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 11ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104509931 description "2020年の論文" @default.
- Q104509931 description "2020年学术文章" @default.
- Q104509931 description "2020年学术文章" @default.
- Q104509931 description "2020年学术文章" @default.
- Q104509931 description "2020年学术文章" @default.
- Q104509931 description "2020年学术文章" @default.
- Q104509931 description "2020年学术文章" @default.
- Q104509931 description "2020年學術文章" @default.
- Q104509931 description "2020年學術文章" @default.
- Q104509931 description "2020年學術文章" @default.
- Q104509931 description "2020年學術文章" @default.
- Q104509931 description "2020年學術文章" @default.
- Q104509931 description "2020년 논문" @default.
- Q104509931 description "article científic" @default.
- Q104509931 description "article scientific" @default.
- Q104509931 description "article scientifique" @default.
- Q104509931 description "articol științific" @default.
- Q104509931 description "articolo scientifico" @default.
- Q104509931 description "artigo científico" @default.
- Q104509931 description "artigo científico" @default.
- Q104509931 description "artigo científico" @default.
- Q104509931 description "artikel ilmiah" @default.
- Q104509931 description "artikull shkencor" @default.
- Q104509931 description "artikulong pang-agham" @default.
- Q104509931 description "artykuł naukowy" @default.
- Q104509931 description "artículo científico publicado en 2020" @default.
- Q104509931 description "artículu científicu" @default.
- Q104509931 description "bilimsel makale" @default.
- Q104509931 description "bài báo khoa học" @default.
- Q104509931 description "naučni članak" @default.
- Q104509931 description "scienca artikolo" @default.
- Q104509931 description "scientific article published on 11 November 2020" @default.
- Q104509931 description "scientific article published on 11 November 2020" @default.
- Q104509931 description "scientific article published on 11 November 2020" @default.
- Q104509931 description "teaduslik artikkel" @default.
- Q104509931 description "tieteellinen artikkeli" @default.
- Q104509931 description "tudományos cikk" @default.
- Q104509931 description "vedecký článok" @default.
- Q104509931 description "vetenskaplig artikel" @default.
- Q104509931 description "videnskabelig artikel udgivet 11. november 2020" @default.
- Q104509931 description "vitenskapelig artikkel" @default.
- Q104509931 description "vitskapeleg artikkel" @default.
- Q104509931 description "vědecký článek" @default.
- Q104509931 description "wetenschappelijk artikel" @default.
- Q104509931 description "wissenschaftlicher Artikel" @default.
- Q104509931 description "επιστημονικό άρθρο" @default.
- Q104509931 description "мақолаи илмӣ" @default.
- Q104509931 description "наукова стаття, опублікована 11 листопада 2020" @default.
- Q104509931 description "научна статия" @default.
- Q104509931 description "научная статья" @default.
- Q104509931 description "научни чланак" @default.
- Q104509931 description "научни чланак" @default.
- Q104509931 description "מאמר מדעי" @default.
- Q104509931 description "مقالة علمية نشرت في 11 نوفمبر 2020" @default.
- Q104509931 description "১১ নভেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q104509931 description "บทความทางวิทยาศาสตร์" @default.
- Q104509931 description "სამეცნიერო სტატია" @default.
- Q104509931 name "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 name "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 name "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 type Item @default.
- Q104509931 label "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 label "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 label "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 prefLabel "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 prefLabel "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 prefLabel "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 P1433 Q104509931-B6F18C9F-D70A-460F-8410-E98E7189A0EA @default.
- Q104509931 P1476 Q104509931-BFF68BEB-4447-415F-A028-8496E8F94C1D @default.
- Q104509931 P2093 Q104509931-1F84283C-45C0-41BA-91E8-9D23CA0863CF @default.
- Q104509931 P2093 Q104509931-3AAD4132-EE81-47ED-8BF2-D38EB7EB208C @default.
- Q104509931 P2093 Q104509931-98F541AD-AEC5-46E9-9DFE-A27EF3F7B014 @default.
- Q104509931 P2093 Q104509931-E8D9F749-18C8-4AEC-A1EC-A3C91F3C4D18 @default.
- Q104509931 P304 Q104509931-FF47573E-F9AC-4D4F-A462-94E5082BCB38 @default.
- Q104509931 P31 Q104509931-8BB82D15-C191-4E2A-BFA6-EFD6725F45B8 @default.
- Q104509931 P356 Q104509931-833C04F7-38A2-4F67-B5D8-E4D4E5A59D64 @default.
- Q104509931 P433 Q104509931-1D66F8DC-305B-4013-80A4-BBE1B1DB8259 @default.
- Q104509931 P478 Q104509931-46C66F93-9A02-4D1A-B729-38E4566297B2 @default.
- Q104509931 P577 Q104509931-E0801B6C-321F-43C2-94A1-4B3E4985B1CE @default.
- Q104509931 P698 Q104509931-92AB593C-4229-4661-AAB8-8A7B913FC238 @default.
- Q104509931 P921 Q104509931-14E122A6-4946-4689-8740-B1D1AE050C43 @default.
- Q104509931 P921 Q104509931-16D745E1-AC3C-4B01-A84B-8D4E9204824E @default.
- Q104509931 P921 Q104509931-527BD66B-F1AC-456C-B407-9A8C7E65BB1C @default.
- Q104509931 P356 ACSPTSCI.0C00144 @default.
- Q104509931 P698 33344906 @default.
- Q104509931 P1433 Q96320347 @default.
- Q104509931 P1476 "Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies" @default.
- Q104509931 P2093 "Ahmed A Al-Karmalawy" @default.
- Q104509931 P2093 "Mohamed F Elshal" @default.
- Q104509931 P2093 "Rasha M Saleh" @default.
- Q104509931 P2093 "Shenouda G Eliaa" @default.
- Q104509931 P304 "1330-1338" @default.
- Q104509931 P31 Q13442814 @default.
- Q104509931 P356 "10.1021/ACSPTSCI.0C00144" @default.
- Q104509931 P433 "6" @default.
- Q104509931 P478 "3" @default.
- Q104509931 P577 "2020-11-11T00:00:00Z" @default.